Skip to main content
. 2018 Mar 19;153:70–77. doi: 10.1016/j.antiviral.2018.03.005

Table 2.

Summary of total symptom scores (Days 1–8).

PrEP-001 Placebo
Study 1
N 22 22
Median (range) 4.5 (0–71) 38.5 (0–106)
Mean (SE) 10.2 (3.89) 40.6 (7.18)
95% CI 2.1, 18.3 25.7, 55.5
Difference PrEP-001/placebo −30.4
95% CI −46.9, −13.9
Study 2
N 25 27
Median (range) 4 (0–39) 8 (0–92)
Mean (SE) 9.1 (1.83) 20.6 (3.97)
95% CI 5.3, 12.9 12.3, 28.9
Difference PrEP-001/placebo −11.5
95% CI −20.1, −2.9